Dr. Lorraine D. Cornwell is a specialist cardiothoracic surgeon at the Michael E. DeBakey VA Medical Center in Houston, Texas. Her practice is directed toward providing state-of-the-art thoracic oncologic and cardiac surgical services to the country’s military veterans diagnosed with an array of diseases and conditions, including asbestos-related lung cancer and pleural mesothelioma. Education and
Malignant mesothelioma is challenging for numerous reasons. Always fatal, mesothelioma remains latent for decades before appearing in an aggressive and fast-moving way. Making matters worse, the condition’s rarity limits scientists’ ability to test new treatments. To address this, Australian researchers have explored using pleural effusion samples from patients to create models called “organoids” on which
Dr. Christine Lau is a thoracic surgeon and a renowned lung transplant surgeon. She is the Chief of Surgery at the University of Maryland School of Medicine in Baltimore, Maryland, as well as the Chief of Surgery at the University of Maryland Medical Center. She has significant experience in treating patients with thoracic illnesses and injuries
Dr. Robert C. Miller is a nationally recognized radiation oncologist and the Vice Chair for Strategic Engagement at Indiana University Health’s Department of Radiation Oncology. Dr. Miller has extensive experience in cancer care and using radiation therapy for the treatment of pleural mesothelioma, lung cancer, and other thoracic malignancies. His primary focus is on the
Dr. Pranshu Mohindra is a radiation oncologist at the University Hospitals Cleveland Medical Center in Cleveland, Ohio. He serves as Professor and Vice-Chair of Operations and Quality for the Department of Radiation Oncology and the Director of the University Hospitals Proton Therapy Center. He specializes in treating thoracic cancers, including pleural mesothelioma. Education and Career
Malignant mesothelioma is one of the most challenging diseases confronting modern medicine. The aggressive form of asbestos-related cancer has been resistant to traditional therapies, stymying researchers, frustrating physicians, and devastating patients and their families. A recent study examining variations in lung cancer microenvironments has yielded information that may provide new answers and avenues of exploration
Dr. Prakash Neupane is a medical oncologist at the University of Kansas Medical Center in Kansas City, where he specializes in the care of patients with head and neck cancers and thoracic cancers, including lung cancer and pleural mesothelioma. In addition to his clinical role, he is a Professor of Medical Oncology, Program Director of
Dr. Gaurav Marwaha is a radiation oncologist, associate professor, and interim chairperson in the Department of Radiation Oncology at Rush University Medical Center in Chicago, Illinois. His areas of expertise include the use of intensity-modulated radiation therapy, palliative radiation therapy, and stereotactic radiosurgery for the treatment of patients diagnosed with lung cancer and pleural mesothelioma,
Dr. Arkadiusz Z. Dudek is a medical oncologist and researcher at the Mayo Clinic in Rochester, Minnesota. He is actively involved in developing new cancer therapeutics for lung cancer, malignant mesothelioma, kidney cancer, and melanoma, as well as other advanced malignancies. His focus is on identifying targets for therapies in order to lead to improvements in
Dr. Renuka Malik is a radiation oncologist and associate professor of radiaation and cellular oncology at the University of Chicago Medicine in Chicago, Illinois. She specializes in the treatment of thoracic, gastrointestinal, and oligometastatic cancers including pleural mesothelioma, peritoneal mesothelioma, and lung cancer, as well as gynecologic cancers, prostate cancer, breast cancer, and head and